Get the latest updates

Section Title

Recommended for you

Text

Based on your evaluation answers do you want to add any the following products to your treatment plan? These are one time purchases.

StandardButton

Core:Section

selected

Select

Addons

Rybelsus is an FDA-approved prescription medication for adults with type 2 diabetes mellitus. As the first oral GLP-1 receptor agonist, it mimics natural hormones to stimulate insulin release, regulate glucose levels, and slow digestion—helping to manage blood sugar effectively. Clinical studies have shown that patients on the highest dose (14 mg) experienced improved blood sugar control and an average weight loss of 4.4 kg over 52 weeks. Rybelsus is intended to be used alongside diet and exercise to improve glycemic control in patients with type 2 diabetes.

Full Description

• Prescription Consultation – A licensed healthcare professional will assess your suitability for Rybelsus.• Convenient Home Delivery – Get your medication delivered discreetly to your door.• Ongoing Support – Our medical team provides follow-up guidance for safe and effective use.

In this plan

• Clinically Proven – Shown to lower blood sugar levels and support weight loss in patients with type 2 diabetes.• First Oral GLP-1 Medication – No need for injections; easy-to-take daily tablet.• Supports Insulin Regulation – Stimulates the body’s natural insulin response to control blood sugar.• Gradual Dose Adjustment – Available in 3 mg, 7 mg, and 14 mg to optimize effectiveness.• May Support Weight Loss – Clinical trials showed patients lost an average of 4.4 kg over 52 weeks.

Features

• Take 1 tablet daily in the morning with a sip of plain water (no more than 120 mL). • Wait at least 30 minutes before eating, drinking, or taking other medications. • Dosing Schedule:<ul><li>• Start with 3 mg once daily for the first 4 weeks.</li><li>• Increase to 7 mg daily.</li><li>• If needed, increase to 14 mg daily for maximum benefit.</li></ul> • Follow your doctor’s advice on usage and continue a balanced diet and exercise plan for optimal results.

Directions

• A 52-week clinical trial found that participants on 14 mg of oral semaglutide lost an average of 4.4 kg while improving blood sugar control.*• Another study on 667 patients found that oral semaglutide (50 mg) resulted in 15.1% weight loss. ** <h6>*DOI: 10.1016/S0140-6736(19)31271-1</h6><h6>**Clinical Study by Novo Nordisk</h6>

Rybelsus 14mg

Rybelsus 14mg

Get the latest updates